Ironwood Pharmaceuticals, Inc. (IRWD)
NASDAQ: IRWD · Real-Time Price · USD
3.280
-0.180 (-5.20%)
At close: Jun 2, 2026, 4:00 PM EDT
3.261
-0.019 (-0.59%)
After-hours: Jun 2, 2026, 7:58 PM EDT

Ironwood Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Jun '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
5405507101,7891,9081,889
Market Cap Growth
461.84%-22.57%-60.32%-6.27%1.01%3.28%
Enterprise Value
916.82728.921,2172,2091,6651,625
Last Close Price
3.283.374.4311.4412.3911.66
PE Ratio
5.3122.47443.00-12.913.63
Forward PE
2.907.8413.4214.1411.248.43
PEG Ratio
---1.982.251.21
PS Ratio
1.491.862.024.044.654.57
PB Ratio
--2.10-2.36-5.172.933.12
P/TBV Ratio
-2.58-2.10-2.35-5.133.543.16
P/FCF Ratio
4.814.336.869.776.977.22
P/OCF Ratio
4.814.336.859.756.977.21
EV/Sales Ratio
2.542.463.464.994.063.93
EV/EBITDA Ratio
4.507.2612.80-6.616.95
EV/EBIT Ratio
4.547.4013.07-6.657.00
EV/FCF Ratio
8.175.7411.7712.066.096.21
Debt / Equity Ratio
-1.82-1.51-1.98-1.480.630.59
Debt / EBITDA Ratio
2.965.966.30-1.652.04
Debt / FCF Ratio
5.324.715.803.911.521.82
Net Debt / Equity Ratio
-1.74-1.46-1.70-1.80-0.37-0.24
Net Debt / EBITDA Ratio
1.873.815.37-0.66-0.95-0.62
Net Debt / FCF Ratio
3.363.014.943.40-0.88-0.55
Asset Turnover
0.870.790.860.560.370.49
Quick Ratio
1.381.084.390.8030.234.54
Current Ratio
1.411.134.690.8430.584.61
Return on Equity (ROE)
-100.53%-41.21%-40.00%-564.93%52.42%-38.03%
Return on Assets (ROA)
67.61%43.65%45.01%-109.72%29.37%-17.45%
Return on Invested Capital (ROIC)
89.08%59.10%55.46%-199.96%70.72%-43.89%
Return on Capital Employed (ROCE)
113.44%42.21%36.73%-148.89%24.54%31.13%
Earnings Yield
18.92%4.45%0.23%-7.75%27.53%
FCF Yield
20.78%23.11%14.57%10.24%14.34%13.85%
Buyback Yield / Dilution
-2.82%-1.81%-2.99%16.57%-13.32%-2.34%
Total Shareholder Return
-2.82%-1.81%-2.99%16.57%-13.32%-2.34%
SEC Filings: 10-K · 10-Q